Skip to main content
Psychedex

5-MeO-DiPT

5-methoxy-N,N-diisopropyltryptamine

1Provenance card

the boundary, as counts

Sources

3622 with DOI

3 strong · 26 moderate · 7 weak

Compilations

12026-04-26T14:29:35.748Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

31last ruled 2026-06-04

0 awaiting a ruling

Issued documents

52026-10-19T20:30:14.317Z

notice · info card · emergency

Searches

283 with no results

queries and counts on the build

Claims checked

16849 supported

49 supported · 119 not

Correspondence

0received

consent field ships in Phase 4

Edges

446

derivations recorded for this entity

Complete over 36 sources, 1 compilation, and 31 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/5-meo-dipt/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued emergency
  2. 2026-10-19issueIssued info_card
  3. 2026-09-24srcMetabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine
  4. 2026-09-24srcDual actions of 5-MeO-DIPT at the serotonin transporter and serotonin 5-HT1A receptor in the mouse striatum and prefrontal cortex.
  5. 2026-09-24srcThe hallucinogenic world of tryptamines: an updated review.
  6. 2026-09-24srcEffects of exposure to 5-MeO-DIPT during adolescence on brain neurotransmission and neurotoxicity in adult rats
  7. 2026-09-24srcNeurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats.
  8. 2026-09-24srcReceptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
  9. 2026-09-24srcA systematic study of changes in monoamine neurotransmitters in the rat brain following acute administration of alpha-methyltryptamine (AMT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DiPT).
  10. 2026-09-24srcThe effect of repeated-intermittent exposure to 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) during adolescence on learning and memory in adult rats.
  11. 2026-09-24srcDiscriminative Stimulus Effects of Substituted Tryptamines in Rats
  12. 2026-09-24srcStructure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties
  13. 2026-09-24srcStructural pharmacology and therapeutic potential of 5-methoxytryptamines.
  14. 2026-09-24srcRecreational drug use and related social factors among HIV-positive men in Japan.
  15. 2026-09-24srcEffects of three tryptamines: alpha-methyltryptamine, 5-methoxy-alpha-methyltryptamine, and 5-methoxy-N,N-diisopropyltryptamine on acute toxicity, locomotor activity, and hallucinogenic behavior in mice.
  16. 2026-09-24srcDesigner drugs as a cause of homicide.
  17. 2026-09-24srcAbuse liability profile of three substituted tryptamines
  18. 2026-09-24srcPharmacologic Activity of Substituted Tryptamines at 5-HT2A, 5-HT2C, 5-HT1A Receptors and SERT
  19. 2026-09-24srcProlonged delusional state triggered by repeated ingestion of aromatic liquid in a past 5-methoxy-N,N-diisopropyltryptamine abuser.
  20. 2026-09-24srcIndolealkylamines: biotransformations and potential drug-drug interactions
  21. 2026-09-24srcPsychedelics and the human receptorome
  22. 2026-09-24srcClinical toxicology of newer recreational drugs.
  23. 2026-09-24srcToxicology and Analysis of Psychoactive Tryptamines.
  24. 2026-09-24srcPrevalence of HIV infection and related risk behaviors among male new-type drug users in Qingdao, Shandong province.
  25. 2026-09-24srcThe paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors.
  26. 2026-09-24srcSchedules of controlled substances: temporary placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into Schedule I. Final rule.
  27. 2026-09-24src5-MeO-DiPT (CID 151182)
  28. 2026-09-24srcSchedules of controlled substances: placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into schedule I of the Controlled Substances Act. Final rule.
  29. 2026-09-24srcA general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS.
  30. 2026-09-24srcHallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.
  31. 2026-09-24srcOxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes.
  32. 2026-09-24srcFoxy methoxy: a new drug of abuse.
  33. 2026-09-24srcNeuropsychotoxicity of abused drugs: molecular and neural mechanisms induced by methamphetamine, MDMA, and 5-MeO-DiPT.
  34. 2026-09-24srcN,N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity.
  35. 2026-09-24src5-MeO-DiPT Basics (Erowid)
  36. 2026-09-24srcFoxy Fast Facts (National Drug Intelligence Center)
  37. 2026-09-24srcUK Psychoactive Substances Act 2016 and 5-MeO compounds
  38. 2026-09-24src5-MeO-DiPT Physical Properties
  39. 2026-09-04issueIssued emergency
  40. 2026-09-04issueIssued info_card
  41. 2026-09-04issueIssued notice
  42. 2026-06-04proposal29 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  43. 2026-06-04publicationPublication — backfill
  44. 2026-04-26revisionRevision 1
  45. 2026-04-26absenceSearched ClinicalTrials.gov for "5-MeO-DiPT foxy methoxy tryptamine" — no results
  46. 2026-04-26absenceSearched PubMed for "5-MeO-DIPT SERT 5-HT2A 5-HT1A receptor" — no results
  47. 2026-04-26absenceSearched PubMed for "5-methoxy-N,N-diisopropyltryptamine receptor binding serotonin affinity" — no results
  48. 2026-04-26genGeneration — pipeline-v5pipeline-v5
  49. 2026-04-26rungeneration run

The same entries, as forms: six forms.